Evaluation of weekly intramuscular methotrexate in the treatment of low risk gestational trophoblastic neoplasia.

Background: The gestational trophoblastic neoplasms (GTNs) are rare and potentially life-threatening malignancies.

Aims: The aim of this study was to determine the rate of response to weekly intramuscular (IM) methotrexate (MTX) in patients with low-risk GTN (LR-GTN).

Settings And Design: The study was designed cross-sectional and prospectively.